Research Article
The Analysis of Dynamic Changes and Prognosis of Posner–Schlossman Syndrome with Cytomegalovirus Infection and Antiviral Therapy
Table 2
Comparison of patients from the CMV-positive and CMV-negative group.
| | CMV positive (N = 36) | CMV negative (N = 28) | value |
| IOP of the affected eye, mmHg | 24.25 ± 11.17 | 25.57 ± 10.98 | — | Coin-shaped KP | At the onset | 9/36 | 8/28 | — | At the last visit | 1/36 | 1/28 | — | ECD, cells/mm2 | 2278.45 ± 355.63 | 2557.62 ± 314.27 | 0.005 | CDR | 0.58 ± 0.22 | 0.46 ± 0.16 | 0.017 | Number of cases achieved all-KP disappearance | 18/36 | 12/28 | — | Cumulative steroids dosage, drops | 204.56 ± 195.67 | 129.50 ± 125.02 | — | Cumulative ganciclovir eye drops dosage (drops) | 567.00 ± 867.45 | 0 | — | Cumulative treatment time (weeks) | 21.44 ± 34.67 | 10.08 ± 7.53 | — | Steroids dosage per day at the last visit (times/day) | 0.61 ± 0.78 | 0.75 ± 0.97 | — | Number of cases exempted from steroids | 10/18 | 7/12 | — |
|
|
IOP = intraocular pressure. CMV = cytomegalovirus. ECD = endothelial cell density. CDR = cup-to-disc ratio. KP = keratic precipitate. Student’s t-tests. |